The Biobetters market size is expected to reach $121.61 billion in 2030 at a CAGR of 9.7%, driven by increasing prevalence of chronic and autoimmune diseases.
Read More
The Biosimilars market size is expected to reach $48.52 billion in 2030 at a CAGR of 17.4%, driven by increasing healthcare expenditures worldwide.
Read More
The Biobased Disinfectant market size is expected to reach $9.46 billion in 2030 at a CAGR of 9.6%, driven by growing awareness of environmental sustainability.
Read More
The Biosimilar Therapeutic Peptides market size is expected to reach $6.11 billion in 2030 at a CAGR of 11.9%, driven by rising prevalence of chronic diseases.
Read More
The Biguanides market size is expected to reach $5.97 billion in 2030 at a CAGR of 3.1%, driven by rising prevalence of diabetes and metabolic disorders.
Read More
The Biosimilar Monoclonal Antibodies market size is expected to reach $14.58 billion in 2030 at a CAGR of 6.6%, driven by growing autoimmune disease prevalence.
Read More
The Bevacizumab Biosimilars market size is expected to reach $2.42 billion in 2030 at a CAGR of 8.2%, driven by rising global prevalence of cancer cases.
Read More
The Beta Blockers market size is expected to reach $13.96 billion in 2030 at a CAGR of 6.6%, driven by increasing incidence of cardiovascular diseases globally.
Read More
The Biosimilar Lymphocyte Modulator market size is expected to reach $3.53 billion in 2030 at a CAGR of 11.1%, driven by rising incidence of autoimmune disorders.
Read More
The Benzodiazepine Drugs market size is expected to reach $5.07 billion in 2030 at a CAGR of 6.0%, driven by rising prevalence of anxiety and mental health disorders.
Read More